BPC-157 Dosage Calculator: Your Complete Guide to Tissue Healing

What is BPC-157 and How Does It Work?

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide, meaning it consists of 15 amino acids. It's derived from a protective protein naturally found in human gastric juice, which helps maintain the integrity of the digestive tract.

The peptide has gained significant attention for its potential to accelerate healing across multiple tissue types, including tendons, ligaments, muscles, and even the gut lining.

How BPC-157 works: Research suggests BPC-157 promotes healing through several mechanisms:

• Angiogenesis: Stimulates formation of new blood vessels, improving oxygen and nutrient delivery to injured tissues
• Growth factor upregulation: Increases expression of growth factors involved in tissue repair, including VEGF and EGF-1
• Collagen synthesis: Enhances fibroblast activity and collagen production for connective tissue repair
• Nitric oxide modulation: Affects NO pathways to support vascular healing and blood flow
• Anti-inflammatory effects: Reduces inflammatory cytokines at injury sites

BPC-157 Benefits and Research Applications

BPC-157 has been studied for multiple healing and protective applications:

BPC-157 Dosage Protocols

Dosing varies based on the condition being treated, body weight, and administration route.

Standard Dosing by Goal

Dosing by Body Weight

Split Dosing vs Single Daily Dose

Many protocols split the daily dose into two administrations (morning and evening) to maintain more consistent peptide levels. However, single daily dosing is also effective.

Split dosing example: 300 mcg total daily = 150 mcg morning + 150 mcg evening

How to Calculate Your BPC-157 Dose

Calculating your dose requires understanding the relationship between vial concentration, syringe units, and your target mcg dose.

Step 1: Determine Your Vial Concentration

After reconstitution, your concentration depends on how much bacteriostatic water you add:

Step 2: Calculate Units on Your Syringe

Using a standard U-100 insulin syringe (100 units = 1 ml):

Formula: Units to draw = (Desired dose in mcg / Concentration in mcg/ml) x 100

Example calculations for 5 mg vial reconstituted with 1 ml (5000 mcg/ml = 5 mg/ml):

Example calculations for 5 mg vial reconstituted with 2 ml (2500 mcg/ml = 2.5 mg/ml):

Quick Reference Cards

For a 5 mg vial reconstituted with 1 ml bacteriostatic water (5 mg/ml):

For a 10 mg vial reconstituted with 2 ml bacteriostatic water (5 mg/ml):

Reconstitution: Mixing Your BPC-157 Properly

Proper reconstitution ensures your peptide maintains potency and delivers accurate doses.

What You Need

• BPC-157 lyophilized powder vial
• Bacteriostatic water (contains 0.9% benzyl alcohol as preservative)
• Sterile syringes (one for mixing, separate ones for injections)
• Alcohol swabs
• Clean, flat work surface

Reconstitution Process

1. Prepare your workspace: Clean your surface and wash your hands thoroughly. Gather all supplies before starting.

2. Clean the vial tops: Wipe the rubber stoppers of both the BPC-157 vial and bacteriostatic water with alcohol swabs. Allow to air dry completely.

3. Draw the bacteriostatic water: Using a sterile syringe, draw your calculated amount of bacteriostatic water.

4. Add water to the BPC-157 vial: Insert the needle at an angle, aiming the stream at the glass wall rather than directly onto the powder. Add water slowly to avoid foaming.

5. Allow to dissolve: Let the vial rest for 10-20 minutes. The powder should dissolve on its own. If needed, gently roll the vial between your palms. Never shake the vial as this can damage the peptide.

6. Inspect the solution: The reconstituted BPC-157 should be clear and colorless. Do not use if cloudy, discolored, or containing visible particles.

Storage After Reconstitution

• Refrigerate at 36-46°F (2-8°C) immediately after mixing
• Keep away from light
• Use within 4 weeks of reconstitution (bacteriostatic water provides preservative protection)
• Lyophilized (unreconstituted) powder can be stored frozen at -4°F (-20°C) for extended shelf life
• Avoid repeated freeze-thaw cycles

Administration Protocol

Choosing Your Administration Route

Subcutaneous injection (most common): Best for systemic healing effects and general tissue repair. Inject into fatty tissue beneath the skin.

Intramuscular injection: Can be used for localized muscle injuries. Requires longer needles and should be performed under professional guidance.

Oral/sublingual: Best suited for gut-related conditions (ulcers, IBS, leaky gut). Lower bioavailability than injections but may work locally on digestive tissue.

Injection Site Selection

For systemic effects:

• Abdomen (2 inches away from navel)
• Front or outer thigh
• Back of upper arm

For localized healing: Inject within 2-3 inches of the injury site when targeting specific areas like tendons or joints.

Site rotation: Rotate injection sites with each dose to prevent tissue irritation.

Timing Your Injection

There's no universally "best" time to inject BPC-157, but common approaches include:

• Morning: Start the day with healing support
• Before bed: Support natural overnight repair processes
• Post-workout: For injury-specific cases, timing after exercise may support recovery
• Split dosing: Morning and evening for more consistent levels

Weekly Schedule

Standard Protocol: Daily subcutaneous injection for the duration of the treatment cycle (typically 4-8 weeks).

Some practitioners recommend brief breaks (e.g., 5 days on, 2 days off), but most protocols use continuous daily dosing.

Treatment Phases and What to Expect

Week 1: Initial Response

Your body is beginning to respond to BPC-157. Effects are subtle but the healing cascade is starting.

What to expect:

• Possible reduction in pain and inflammation at injury site
• Mild injection site reactions (normal, temporary)
• Subtle improvements in comfort

Weeks 2-4: Active Healing

Benefits become more noticeable as tissue repair accelerates.

What to expect:

• Noticeable reduction in pain and inflammation
• Improved mobility and range of motion
• Visible progress in injury recovery
• Enhanced exercise tolerance

Weeks 4-8: Consolidation

Full benefits typically manifest by week 4-8 depending on injury severity.

What to expect:

• Significant tissue healing
• Restored function
• Continued improvement even after stopping (healing momentum)

Cycle Duration

• Mild to moderate injuries: 2-4 weeks
• Moderate injuries: 4-6 weeks
• Severe or post-surgical: 6-8 weeks, sometimes extending to 12 weeks
• Gut health conditions: 4-6 weeks

After completing a cycle, a 2-4 week break is typically recommended before starting another cycle if needed.

Signs Your Dose May Need Adjustment

Signs Your Dose May Be Too Low

• No improvement in pain or inflammation after 2 weeks
• Minimal changes in healing progress
• Slow recovery despite consistent dosing

Signs Your Dose May Be Too High

• Unusual fatigue or lethargy
• Persistent injection site reactions
• Any unexpected symptoms

Most Common Side Effects

BPC-157 is generally well-tolerated based on available research. Reported side effects are typically mild:

• Injection site reactions (redness, mild irritation)
• Nausea (rare, more common with oral administration)
• Dizziness (rare)
• Headache (rare)

BPC-157 Stacking Options

BPC-157 is commonly combined with other peptides for enhanced healing effects. Always consult with a healthcare provider before combining therapies.

BPC-157 vs TB-500: Key Differences

These two peptides are often compared and sometimes combined for tissue healing:

Common Questions

How long until I see results?

Most users notice improvements within 7-10 days, especially in pain reduction and mobility. Significant tissue healing typically occurs over 4-8 weeks.

Should I inject near the injury or away from it?

For localized injuries (tendons, joints), injecting within 2-3 inches of the injury site may provide more targeted benefits. For systemic effects or gut health, standard subcutaneous sites work well.

Can I take BPC-157 orally?

Yes, oral BPC-157 (capsules or sublingual) is used primarily for gut health conditions. For musculoskeletal healing, injectable forms are more effective due to higher bioavailability.

Should I avoid NSAIDs while taking BPC-157?

Some research suggests NSAIDs may counteract BPC-157's healing effects. Discuss pain management options with your healthcare provider.

Can I combine BPC-157 with TB-500?

Yes, this is a popular combination. The peptides work through different mechanisms and may provide synergistic healing effects. They can often be combined in the same syringe.

Is BPC-157 banned in sports?

Yes, BPC-157 is prohibited by WADA and most sports organizations.

Working With Your Healthcare Provider

BPC-157 therapy should be supervised by a healthcare provider. Your provider should:

• Evaluate your injury or condition and determine if BPC-157 is appropriate
• Help select the right dose and administration route for your goals
• Monitor your healing progress
• Adjust the protocol based on your response
• Screen for contraindications and potential interactions

Be proactive in communicating with your provider about your progress, any side effects, and your treatment goals.

Important Safety Information

• BPC-157 is not FDA-approved and is classified as a Category 2 bulk drug substance
• It is banned in competitive sports by WADA
• Compounded BPC-157 is not FDA-reviewed for safety, quality, or efficacy
• Long-term human safety data is lacking
• Potential concern: BPC-157 promotes angiogenesis, which theoretically could affect tumor growth (discuss with your provider if you have a history of cancer)
• Do not use if pregnant or breastfeeding
• Report any unusual symptoms to your healthcare provider promptly
• Store and handle your medication according to pharmacy instructions
• Never share your medication with others

This information is for educational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider before starting any peptide therapy. Individual results vary based on numerous factors including injury type, severity, and adherence to treatment protocols.

‍